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8478 | Chem. Sci., 2019, 10, 8478–848f methylation and chain-length
programming in a fungal iterative highly reducing
polyketide synthase†
Xiao-Long Yang, ‡ab Steﬀen Friedrich,ab Sen Yin,ab Oliver Piech,ab
Katherine Williams, abc Thomas J. Simpson c and Russell J. Cox *ab
Exchange of 32 diﬀerent sub-fragments of the C-methyltransferase (C-MeT), pseudo-ketoreductase (JKR)
and ketoreductase (KR) catalytic domains of the tenellin iterative Type I polyketide synthase non ribosomal
peptide synthetase (PKS-NRPS) TENS by homologous fragments from the desmethylbassianin (DMBS) and
militarinone (MILS) PKS-NRPS led to the creation of chimeric synthetases in which programming ﬁdelity was
altered, resulting in the production of mixtures of products with diﬀerent methylation patterns and chain
lengths. Swap of KR domain subfragments with the homologous fragments from the KR of the
heptaketide militarinone synthetase resulted in the synthesis of penta, hexa and heptaketides. The results
of these and previous experiments are rationalised by considering the existence of competition for acyl-
carrier protein (ACP) bound substrates between diﬀerent catalytic domains of the PKS. In particular,
competition between the C-MeT and ketoreductase domains (KR) can account for methylation
programming, and competition between the KR and the oﬀ-loading NRPS accounts for chain-length
selectivity.Introduction
All known fungal polyketide synthases (PKS) are multi-
functional proteins which control starter unit selection and
the programming of chain length and methylation.1 Since these
proteins are almost universally iterative, they have the ability to
catalyse diﬀerent sets of reactions during each extension cycle
using the same manifest of catalytic components. In the case of
highly reducing fungal PKS (hr-PKS), the programming is
particularly complex because specic C-methylation, reduction,
dehydration and enoyl reduction reactions can occur during
each cycle. While some aspects of programming in non-
reducing Type I and II PKS (nr-PKS)2 are understood – particu-
larly the roles of starter unit acyl transferase (SAT)3 domains and
product template (PT)4 domains, and chain-length selection in
Type II PKS,5 the features controlling programming in Type I hr-
PKS remain cryptic. For example, during the biosynthesis of the
pretenellin A 16 polyketide (Scheme 1), methylation occurs atniversity of Hannover, Schneiderberg 1B,
cox@oci.uni-hannover.de
, Schneiderberg 38, 30167, Hannover,
antock's Close, Bristol, BS8 1TS, UK
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ical Sciences, South-Central University
ina.
9the diketide and triketide stages, but not at the tetra- and
pentaketide stages. This selectivity is enacted by a single cata-
lytic C-methyltransferase (C-MeT) domain. The determinant of
chain-length in these systems is not known.
Since hr-PKS are responsible for the biosynthesis of
numerous biologically important compounds, e.g. the myco-
toxic cytochalasans,7 the anticholesterol lovastatin8 and squa-
lestatins9,10 and the antifungal strobilurins,11 discovering the
mechanism of the programming is an important goal if the
rational engineering of these systems is to be achieved. This
goal is diﬃcult to reach in the absence of structural data for
complete fungal hr-PKS which have thus far resisted attempts to
crystalise them – although structural data is available for
a limited number of isolated or trans-acting domains.12,13
However, since fungal hr-PKS are closely related at the peptide
sequence level to mammalian fatty acid synthases (mFAS, Fig. 1)
for which complete structures are known,14 mFAS can be used
as a useful guide.15
In the rst experiments to successfully probe the program-
ming mechanism in hr-PKS, we showed that the exchange of
entire functional domains between closely related (but diﬀer-
ently programmed) hr-PKS could lead to the creation of new
polyketides (Scheme 1).16 We used the pretenellin A 1 and pre-
desmethylbassianin A (preDMB A, 2) synthetases (TENS and
DMBS respectively). These PKS-NRPS proteins, each of approx-
imately 600 kDa, consist of a typical fungal hr-PKS with an NRPS
fused at the C-terminus. Pretenellin A 1 and predes-
methylbassianin A 2 belong to a large family17 of fungalThis journal is © The Royal Society of Chemistry 2019
Scheme 1 Domain structure and swaps of iterative polyketide synthases: cartoon views of (A), the tenellin PKS-NRPS (TENS) and (B), the
desmethylbassianin PKS-NRPS (DMBS) and their key enzyme-bound intermediates and products; (C), cartoon view of a hybrid PKS-NRPS and its
key intermediate and products. Abbreviations: as Fig. 1 and ER0, non-functional ER domain; C-MeT, C-methyltransferase; DKC, Dieckmann
cyclase; C, condensation domain; A, adenylation domain and T, thiolation domain.
Fig. 1 Cartoon model of the quaternary structure of mammalian fatty
acid synthase (mFAS). Abbreviations: AT, acyltransferase; KS, keto-
synthase; DH, dehydratase; ER, enoyl reductase; JC-MeT, non-
functional C-methyltransferase; KR, ketoreductase; JKR, structural
domain of KR; ACP, acyl carrier protein; TE, thiolesterase.
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View Article Onlinemetabolites which also includes militarinone C 4 (produced by
Paecilomyces militaris ¼ Cordyceps militaris)18 which is a doubly-
reduced trimethylated heptaketide and farinosone A 5 (Paeci-
lomyces farinosus),19 a mono-reduced dimethylated heptaketide.
The tenellin and desmethylbassianin synthetases are 86%
identical,16 but produce polyketides which diﬀer in chain-length
and methylation pattern: the dimethylated pentaketide in 1 and
the monomethylated hexaketide in 2 respectively. By swapping
individual and multi-domain fragments between TENS andThis journal is © The Royal Society of Chemistry 2019DMBS, we determined that some catalytic domains such as b-
ketoacyl synthase (KS), acyl transferase (AT) and acyl carrier
protein (ACP) appear not to be involved in programming. In the
cases of both TENS and DMBS, the PKS proteins are terminated
with a non-ribosomal peptide synthetase (NRPS) module which
catalyses the transfer of the polyketide via an amide linkage to
tyrosine. A Dieckmann cyclisation domain (DKC) then eﬀects
chain-release by intramolecular cyclisation to form the tetra-
mate moiety.20 Exchange of the TENS and DMBS NRPS domains
also had no observed eﬀect on programming (Scheme 1).16
TENS and DMBS both utilise trans-acting enoyl reductase
proteins (ER, TenC and DmbC respectively) and these too can be
exchanged without aﬀecting programming. However,
programming and delity changes are observed in these
systems when the ketoreductase (KR) and C-MeT domains are
swapped,13 and when the trans-acting ER is absent.8,21,22
In particular, it appears that a protein fragment of 503 resi-
dues encompassing the C-MeT and JKR domains (a structural
component of the KR domain) aﬀects both the frequency and
delity ofmethylation. For example, creation of a chimeric PKS in
which the DMBS C-MeT–JKR region is inserted into TENS gives
a synthetase which produces 70% of the novel mono-methylated
metabolite 3, along with 30% of the normal dimethylated TENSChem. Sci., 2019, 10, 8478–8489 | 8479
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View Article Onlinemetabolite 1 (Scheme 1C). Swap of the entire KR domain results
in a mixture of chain lengths, with hexaketides predominating.
Similar reports of reprogramming in related PKS-NRPS systems
have been more latterly reported by Schmidt and co-workers.23
Signicantly no swap of a single domain gives more than
70% of monomethylated material, or hexaketides, but exchange
of the entire C-MeT to KR region gives clean monomethylation
and chain-length (hexaketide) selection suggesting that while
the C-MeT and KR have some intrinsic selectivity (e.g. within
their own active sites), extrinsic factors such as domain–domain
interactions within the PKS may also be signicant determi-
nants of programming.
Here we have examined this phenomenon in more detail by
making a large number of swaps of smaller domain fragments
with the aim of separating intrinsic and extrinsic factors and in
an attempt to obtain cleaner reprogramming eﬀects. In total,
the C-MeT,JKR and KR domains of TENS were divided into 14
sub-fragments and 28 diﬀerent swaps achieved with the corre-
sponding fragments of DMBS (Table 1). Additionally, three
swaps of fragments from the KR domain of the heptaketide
militarinone C 4 synthetase (MILS) were also achieved. Most of
these experiments resulted in functional hybrid PKS systems
and examination of the structures of the products leads toTable 1 Summary of swaps made and LCMS results. Bar graph (top) sh
fragment 1A1 is 92%/81% similar/identical¼ 8%/19% expressed as a diﬀere
Fragment shading also used in Fig. 2 and ESI. Pink bars show donated f
Compounds produced and titre for each swap is shown to the right. Bold
for detailed annotated chromatograms for all experiments
8480 | Chem. Sci., 2019, 10, 8478–8489conclusions about the mechanism of programming within such
PKS and the prospects for their rational engineering.Results
TENS requires the presence of a trans-acting ER protein known
as TenC.6 In previous work we had expressed tenS and tenC
using two parallel expression systems in the fungal host Asper-
gillus oryzae.14 In order to accelerate the work, we cloned tenS
and tenC into a single multi-gene fungal expression vector as
described by Lazarus and coworkers.24 Transformation of this
single vector into A. oryzae and induction of gene expression by
fermentation in media containing maltose leads to the expected
production of the dimethylated pentaketide pretenellin A 1
(Table 1, entry 1) as the major detected compound. The minor
congeners prototenellin A 6 (in which reduction between C-11
and C-12 has not occurred and where methylation occurs at
C-7 and C-11) and a methylation isomer of pretenellin A (most
likely its 11,12-dihydro analogue 7 by MS and UV analysis) are
each observed at less than 4% of the total.
There is no existing structural information for a complete
fungal hr-PKS. However sequence alignment (see ESI†) shows
that mFAS consists of the same catalytic domains as hr-PKSows % diﬀerence in sequence (similarity green, identity mauve), e.g.
nce. Lower table denotes regions of swaps between TENS/DMBS/MILS.
ragments from DMBS; green bars show donated fragment from MILS.
X represent major products. Small x represents minor products. See ESI
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinearranged in the same order.14 Signicant homologies within the
predicted active sites and cofactor-binding regions, coupled
with recent observation that stereochemical preferences for the
catalysed reactions of mFAS and some hr-PKS are identical,25,26
suggest that mFAS is an appropriate model for fungal hr-PKS.
While the mFAS structure gives good information regarding
the likely quaternary arrangement and interactions of the hr-
PKS catalytic domains (Fig. 3A), it was obtained at relatively
low resolution (3.2 A˚).
In particular the mFAS JC-MeT domain is represented
poorly, and signicant deletions and sequence variations from
the PKS C-MeT domain are indicated by the sequence align-
ment (see ESI†). In order to obtain better quality models of the
individual domains of mFAS, and the quaternary structure of
TENS, we created a hybrid model. First a model of the TENS KR
was developed using the X-ray structure of the amphotericin-B
KR AmphB27 (to which TENS shows 27% homology) using
SWISSMODEL28 which gave a satisfactory QMEAN score of
2.82.29–32 NADPH was built into the active site of the KR model
using PyMOL33 and the model minimized in YASARA.34 Ace-
toacetyl pantetheine was docked into the active pocket usingFig. 2 Cloning strategy for rapid fragment swaps of tenS and typical resu
pretenellin A 1 and analogs. See ESI† for full experimental data for each
This journal is © The Royal Society of Chemistry 2019AutoDock VINA,35,36 again followed by YASARA minimisation.
This revealed a substrate-binding helix which is not present in
the mFAS KR structure (Fig. 5B and D).
The same procedure was used to generate a model of the
TENS C-MeT using the CurJ C-MeT37 (to which it is 29%
homologous) as the template. This also resulted in a satisfactory
model structure with a QMEAN score of 3.16.38–40 The KR and
C-MeT domain models were then used to replace the KR and
JC-MeT domains of mFAS using PYMOL to generate an overall
hybrid model of the quaternary structure. Such hybrid models
have been previously used successfully, for example to generate
a model of the quaternary structure of the CurJ PKS by Skiba
and coworkers.38 The hybrid model indicates how the JKR
forms a linking domain between the KR and C-MeT domains
and it shows the possible quaternary structure of the b-pro-
cessing region of TENS. This is illustrated for mFAS in Fig. 3A
where theJC-MeT,JKR and KR are indicated in red, green and
blue respectively. The hybrid model (Fig. 3B) shows that these
domains probably take up a similar quaternary arrangement in
TENS.lts: (A) cloning strategy; (B) typical HPLC trace (diode array detector) of
experiment; (C) structures of isolated compounds.
Chem. Sci., 2019, 10, 8478–8489 | 8481
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View Article OnlineDesign and implementation of fragment swaps
Using the hybrid model we divided the TENS C-MeT–JKR
region (including proposed linker regions) into ten sub frag-
ments of between 30 and 81 residues (Table 1, Fig. 3C). The KR
of TENS was also divided into four sub-regions of approximately
70 amino acids each (Table 1, Fig. 3C). The fragment-exchange
procedure consisted simply of combining overlapping DNA
fragments constructed from tenS or dmbS templates with the
linearised tenS cloning vector and transforming the mixture
into yeast (Fig. 2A).
For example, the exchange of the 32 AA fragment 2A1 (Table
1, exp. 11) into TENS was achieved using a 50 PCR fragment
obtained from tenS, a ca. 150 bp fragment spanning 2A1 from
dmbS with ca. 30 bp tails matching the tenS sequence, and a 30
fragment from tenS. The reconstructed plasmids were rescued
in E. coli and then transferred by in vitro recombination
(Gateway)41 methodology into the expression vector (which
already contained tenC), and this was then transformed into A.
oryzae.
Multiple A. oryzae transformants were selected and then
grown in parallel on media containing maltose, which induces
expression of the hybrid tenS gene, and organic extracts were
prepared and examined using a standardised extraction and
LCMS protocol (Fig. 2B). Sequencing of the A. oryzae host
genomic DNA was performed in all cases to ensure the correct
expected chimeric genes were integrated. All clones were ob-
tained as expected.Fig. 3 Structures and models: (A) overall domain architecture of mFAS. C
MeT; dark green,JKR; dark grey, ER; blue, KR. (B) Model quaternary struc
ER; red C-MeT; green, JKR; blue, KR. (C) Model of b-processing C-Me
peptides. Colours: see Table 1.
8482 | Chem. Sci., 2019, 10, 8478–8489In previous work we exchanged the entire 506-residue C-
MeT–JKR fragment (Table 1, exp. 2), and this resulted in
a switch to the biosynthesis of predominantly the pentaketide
desmethylpretenellin A 3, although pretenellin A 1 itself was
still produced (30%). In order to determine the role of theJKR
in this eﬀect we began here by swapping only the 393 residue C-
MeT-domain itself (Table 1, exp. 3). This resulted in a signi-
cant reduction in titre, but the pentaketides desmethylprete-
nellin A 3 and pretenellin A 1were synthesised as the observable
products.
We next swapped the rst 241 residues of the C-MeT
(fragment 1, exp. 4) which led to a very low yield of predomi-
nantly 1, accompanied by some 3.
Closer investigation of fragment 1 using swaps of increas-
ingly smaller sub-fragments was generally unproductive. Frag-
ments 1A, 1B, 1A1, 1A2 and 1B2 (exp. 18 to 21, and 23, Table 1)
gave no observable products. However, exchange of fragment
1B1 (exp. 22) consisting of 40 residues led to the production of
at least six compounds in overall moderate titre. Pretenellin A 1
was the major component, with 3 and 7 also present as signif-
icant by-products with 6, and the tetraketides 10 and 11 as
minor components.
Exchange of fragment 2, however, was much more produc-
tive. Exchange of the entire fragment 2 (exp. 5) resulted in good
overall production of mainly demethylated 1 and some mono-
methylated 3, with 7 and 8, and again tetraketides 10 and 11
observed. Exchange of the rst and second 3/4s of fragment 2
(exp. 6 and 7) gave a similar result: high titre of 1 and minorolours: light green, KS, AT and linker regions; light grey, DH; red,JC-
ture of TENS b-processing domains. Colours: light grey, DH; dark grey,
T, JKR and KR region of TENS showing the location of the swapped
This journal is © The Royal Society of Chemistry 2019
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View Article Onlineamounts of 3 and 7. Likewise, swap of fragment 2A (exp. 8)
resulted in high titre of diverse compounds: again 1 was the
dominant compound, but pentaketide 6–9 and tetraketide 10
and 11 methylation variants were observed as minor
components.
Notably 3 was absent. The exchange of the central portion of
fragment 2 (2A2 + 2B1, exp. 9) gave similar results, diverse
compounds, but lacking 3. Exchange of fragment 2B (exp. 10)
also gave high titres and all compounds – this time including
a small amount of 3 – were observed.
Individual quarters of fragment 2 were then exchanged.
Transfer of fragment 2A1 (exp. 11) resulted in a system almost
identical to WT, but with an additional low content of 3, while
swap 2A2 (exp. 12) gave a phenotype almost identical to WT.
Swap of fragment 2B1 (exp. 13) gave a WT phenotype with
additional tetraketide methylation isomers 10 and 11.
Replacement of fragment 2B2 (exp. 14) resulted in high diversity
with predominantly 1, with small amounts of pentaketides 3, 6,
7 and 8, and tetraketides 10 and 11 observed.
Next, the JKR and its sub-fragments were exchanged.
Interchange of the entire 144 residueJKR itself (exp. 15) or the
sub-fragments (exp. 16 and 17) resulted in no change in titre or
production of new compounds, although the production of
somewhat more triene 6 was observed compared to the WT
phenotype in experiments 15 and 17. All products were penta-
ketides – no longer or shorter products were observed.
Ten swaps within the KR domain were also achieved. Previ-
ously we showed that swap of the entire TENS KR with its DMBS
analog results in good titres of pentaketides 1 and 3 and the
hexaketides 2 and 12, (exp. 24) with dimethylation (70% total
product) and hexaketides (80%) predominating. Swaps of (and
within) the rst half of the KR were also productive (exp. 25, 27,
28), giving predominantly the pentaketides 1 and 6, but swap of
the second half of the KR (exp. 26) gave low titres with few newFig. 4 Results of MILS KR swap. (A) HPLC analysis of organic extracts res
ESMS-analysis of indicated compounds.
This journal is © The Royal Society of Chemistry 2019compounds, while swap of the nal quarter 5B resulted in an
inactive synthase. Signicantly, only swaps of regions contain-
ing fragment 5A (exp. 26 and 29) which contains the substrate-
contacting helix, resulted in the production of hexaketides 12
and 13 (which is presumably created by adventitious oxygena-
tion in A. oryzae).
Finally, (experiments 31–33) we swapped-in fragments from
the militarinone PKS-NRPS (MILS) from C. militaris.42 Milita-
rinone C 4 is heptaketide congener of pretenellin A 1 which has
three methyl groups and is reduced twice by its trans-acting ER.
Exchange of the entire KR domain resulted in small amounts of
penta- 1, hexa- 12 and heptaketides 14 (Fig. 4), all of which are
dimethylated and singly reduced, with a majority of the hepta-
ketide. Compound 14 is presumably the precursor of farinosone
A 5, and we therefore name it prefarinosone A.
Swap of fragment 5A alone gave a similar distribution of
products, but in around 5-fold higher titre, allowing isolation
and full characterisation of the prefarinosone A 14 (ca.
1.0 mg L1). As expected compounds 1, 12 and 14 show an
increase in lmax from 373 nm for the dieneone 1 to 426 nm for
the tetraeneone 14 (Fig. 4). In a nal experiment a 36 bp sub-
fragment of the KR domain corresponding to residues Q2398
to V2409 of TENS was exchanged. This produced the same
distribution of 1, 12 and 14, but in overall low titre.Structural analysis
Mapping of the residues which are diﬀerent in the TENS and
DMBS b-processing domains onto the model structure showed
that the majority of these are located at solvent-exposed
surfaces, and are thus unlikely to be involved in signicant
intrinsic eﬀects (Fig. 5A). Changed residues which are not
located at surfaces can be divided into two classes. First, those
such as V1433I and V1437M in the C-MeT (1B1) and I2223L andulting from experiment 31; (B) UV analysis of indicated compounds; (C)
Chem. Sci., 2019, 10, 8478–8489 | 8483
Scheme 2 Course of polyketide biosynthesis catalysed by hybrid PKS-
NRPS: (A), ﬁrst condensation and subsequent selectivity; (B) second
condensation and subsequent selectivity; (C) third condensation and
subsequent selectivity; (D) fourth condensation and subsequent
selectivity; (E) ﬁfth condensation and subsequent selectivity. T ¼ NRPS
thiolation domain.
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View Article OnlineV2336I in the KR (4AB) are in buried hydrophobic regions and
unlikely to be in contact with active sites (Fig. 5B). The eﬀect of
changes such as S1350A (1A1) and A1504V (1B2) cannot be
assessed as exchange of these fragments gives inactive
synthases.
Secondly, non-surface residues likely to contact substrates
and cofactors in the C-MeT and KR were identied (Table 2,
Fig. 6). These are located on fragments 1B1, 1B2, 2A1, 2A2, 2B1,
4A, 4B and 5A (8 out of 14, Fig. 5C–E). However, of these, only
fragments 1B1 (C-MeT), 4B and 5A (KR, Fig. 6) contain changes
in these residues. All other fragments contain no changes in
contact-residues and would not be expected to directly alter the
active site upon exchange.
In the case of fragment 1B1, the mutation is the highly
conservative L1451M (Fig. 5C). While swap fragment 1B1 alone
(experiment 22) leads to formation of some 7, which features
a non-standard methylation pattern, this is no more signicant
than observations of 7 arising from swaps not involving frag-
ment 1B1 (e.g. experiments 5–17, Table 1). For fragment 4B
there is variation at position 2341 which contacts the cofactor
only, and change of fragment 4B is not associated with a change
in programming.
In the case of fragment 5A there are ve changes (Table 2,
Fig. 6) in residues which appear to contact the substrate in the
structural model (Fig. 5D) when compared to DMBS. These are
clustered on the substrate-contacting-helix which appears to be
absent from mFAS. Some of these residues (e.g. V2406A) are not
conservative and could be expected to expand the volume of the
active site. Signicantly, swap of fragment 5A alone (experiment
29) leads to production of hexaketides and in particular 12/13 in
which a hexaketide with double methylation is formed as the
major product. This observation is emphasised for the MILS 5A
swap (experiments 31 + 32) where these residues are also
changed and a heptaketide becomes the major product. Swap of
as few as 12 residues fromMILS reproduces this eﬀect, albeit in
lower titre (exp. 33).
Discussion
Overall observations
The programming of the TENS, DMBS and MILS PKS systems
appears to be controlled by four catalytic domains: KS, C-MeT,
KR and the trans-acting ER (Summarised in Scheme 2). Other
domains appear to have their selectivity controlled chemically:
that is, they act on substrates which are chemically competent,
so that for example, the DH domain always acts on ACP-bound
b-alcohols and the AT always supplies extender units. When no
other domain can act, the NRPS C-domain can remove ACP-
bound b-ketothiolesters and release substrates from the
synthetase via the DKC to form the observed tetramic acids.
This is supported by the limited number of reported in vitro
investigations of hr-PKS catalytic domains. We recently showed
that the functional ER domain from squalestatin tetraketide
synthase has low selectivity and is able to eﬀectively reduce
a wide range of enoyl-pantetheines, even including unnatural
isomers and stereoisomers.26 Meanwhile, Vederas and
coworkers have shown that the C-MeT domain from the8484 | Chem. Sci., 2019, 10, 8478–8489lovastatin nonaketide synthase does display tight selectivity for
its substrate, while the KR in the same system is less selective.43
These observations are consistent with a programming
mechanism which arises by competition between the selective
domains for the ACP-bound substrate. For example, aer the
rst chain extension of acetyl ACP 15 to acetoacetyl ACP 16, four
domains (KS, KR, C-MeT and the NRPS C domain) are catalyt-
ically competent to react next. In the cases of TENS, DMBS and
MILS the C-MeT must be signicantly faster than KR to give 17,
but this is still a valid substrate for the KR which reduces it
(more slowly) to the b-alcohol, which is dehydrated and enoyl-This journal is © The Royal Society of Chemistry 2019
Fig. 5 Model structures of: (A) TENSJKR, C-MeT and KR domains showing changed surface residues (black) in comparison to DMBS; (B) TENS
b-processing domains showing non-surface mutations (spheres) in comparison to DMBS; (C) C-MeT domain of TENS with bound SAM and
acetoacetylpantetheine showing likely active site and changed residue L1451 in black; (D) TENS KR domain with bound NADPH and 20-meth-
ylacetoacetylpantetheine. Red residues indicate positions of V2397, S2400, L2401, T2404 and V2406. Cartoon colours (C and D): exchange
peptide colours as Table 1.
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View Article Onlinereduced to give 21. A similar mechanism has very recently been
proposed in nr-PKS systems where C-MeT must compete with
KS for b-keto–ACP species.44 It appears that the NRPS C-domain
is selective for b-ketothiolesters so the only option le for
diketide 21 is chain-extension by KS to provide the triketide 22.
The C-domain must be slower than both C-MeT and KR in
competition for diketides in these cases, as diketide shunts are
never observed. However in some systems, such asThis journal is © The Royal Society of Chemistry 2019cyclopiazonic acid PKS–NRPS45 the C-catalysed oﬄoading of
a diketide via 19 to 20 is the fastest reaction.
The C-MeT domains of TENS and MILS must be faster than
their KR domains aer the second round of extension to give 24
(Scheme 2B), but for DMBS the KR is faster, giving 23. This is
consistent with the C-MeT domain swap (experiments 2 + 3) in
which the TENS C-MeT provides mostly monomethylated
products.Chem. Sci., 2019, 10, 8478–8489 | 8485
Table 2 Summary of changes in non-surface residues in the b-processing domains of TENS as compared to DMBS. See Fig. 6 for detailed
alignment within KR domain
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View Article OnlineThe TENS and DMBS trans-acting ERs cannot reduce trike-
tides, and thus the unsaturated chain is extended again by KS/
AT to provide tetraketide 25. The TENS and DMBS C-MeT
domains cannot methylate tetraketides (although presumably
the MILS C-MeT can, Scheme 2C), so here KR is again fast and
DH must eliminate H2O to form 28 which is again extended by
KS/AT to form the pentaketide 29. At this stage (Scheme 2D) the
TENS KR cannot reduce the b-carbonyl and the default pathway
is oﬄoading by the NRPS C domain to give pentaketide 30 and
subsequently 1. However the MILS and DMBS KR domains are
able to reduce pentaketides quicker than oﬀ-loading, to give 31,
which is then dehydrated to 32.
Triene 32 is extended again by KS/AT to give hexaketide 33.
Again, this is consistent with the DMBS KR swap (experiment
24) which can convert TENS to a hexaketide synthase. This swap
gives amixture of pentaketide and hexaketide products showing
that the donated KR presumably competes poorly with the oﬀ-
loading C-domain. However this is still faster than the TENS
KR which cannot reduce pentaketides. The DMBS KR and C-
MeT domains cannot react with 33 so the default pathway is
again C-catalysed oﬄoading to give hexaketide 34 and then 2
(Scheme 2E).
Finally, if the KR can reduce hexaketides to give 35 (Scheme
2E), aer dehydration the KS/AT will extend the chain again to8486 | Chem. Sci., 2019, 10, 8478–848936, but the resulting heptaketide can only be oﬀ-loaded to
produce 4. This is consistent with the MILS KR swap (experi-
ments 31–33) which are the only swaps to produce heptaketide
products from the TENS chassis. Signicantly no tetraketides
were produced in these experiments, and pentaketide product
was a minority. This also suggests that the MILS KR usually
always outcompetes oﬀ-loading for shorter chains.
These results also illustrate that the TENS KS/AT and DH
domains appear to have little selectivity (forming all chains up to
heptaketides) and the NRPS oﬄoading module most likely acts
on b-ketothiolesters waiting on the ACP. This would suggest that
oﬀ-loading is the slowest step of the entire process, becoming the
default when no other domain can intercept the ACP-bound
substrate, and is unselective with respect to chain-length and
methylation pattern. This is in contrast to kinetic studies of Type
II iterative PKS in which oﬀ-loading is not rate-limiting.46
Mechanisms of selectivity and programming
Thus a mechanism by which competition for substrates by
a limited number of catalytic domains can explain the observed
programming outcomes. The results also show that program-
ming in these iterative PKS arises due to a combination of
intrinsic and extrinsic factors rather than simply as a result of
direct substrate-selectivity of each catalytic domain.This journal is © The Royal Society of Chemistry 2019
Fig. 6 Sequence alignment in the 4B–5A–5B region of the KR domain
(grey bars). Yellow highlight ¼ identity among PKS; green highlight ¼
identity among mFAS; red text ¼ identity among all; C ¼ residues
which contact cofactor; S ¼ residues which contact substrate; B ¼
other buried position with change. Box highlights substrate-binding
helix most closely associated with chain-length selection. See ESI† for
full alignment of all b-processing domains.
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
0 
Ju
ly
 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
1/
1/
20
19
 1
1:
13
:2
5 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineThe clearest evidence for intrinsic selectivity of a catalytic
domain for its substrate comes from the KR domain. Here, our
modelled structure indicates that ve key residues on
a substrate-binding helix appear to form part of the substrate
binding pocket, and the diﬀerence of these residues between
TENS, DMBS and MILS appears to account for the observed
change in KR substrate selectivity and hence chain-length
control. Here swap of fragment 5A for the corresponding frag-
ment from DMBS gave hexaketides, while the same fragment
from MILS species chain-lengths up to heptaketide. This also
corresponds with additional variations in the MILS KR active
site (e.g. L2345A). This result is reinforced by the observation
that exchange of a 12-residue fragment corresponding to Q2398
to V2409 of the TENS KR (Fig. 6) reprogrammes the system to
produce hexa and heptaketides. In-turn, this swap in particular
validates the modelling of the TENS PKS which predicts that
these residues are most likely in contact with the substrate in
the KR active site (Fig. 5D). This sequence is absent or of very
low homology in the FAS and AmphB KR sequences which
correlates with the absence of programming in these systems –
in both cases the mFAS and AmphB KR domains need only
display an unselective ability to reduce the b-ketothiolesters
supplied to them.
This clear evidence for intrinsic selectivity in the KR domain,
however, is lacking for the C-MeT domain where there appears
to be no signicant changes in the active site itself. Evidence for
the operation of extrinsic programming eﬀects in the TENS PKS
is widespread.This journal is © The Royal Society of Chemistry 2019First, programming changes are usually not limited to
changing a single structural factor of the product. For example,
swap of C-MeT fragment 2A (experiment 8) leads to the
production of tetra- and pentaketides with a range of methyla-
tion patterns (6, 7, 8, 9, 10 and 11) indicative of changes in both
C-MeT and KR selectivity (i.e. their relative rates). Even within
the KR domain, very precise exchanges, such as those enacted
in experiment 33 in which only 12 residues were changed, lead
to mixtures and lowered titres.
Second, unreduced compounds 6, 8, 10 and 11 must arise
through inactivity of the trans-acting ER TenC which we did not
change in these experiments. This suggests that TenC does not
interact with a ‘free’ substrate-bound ACP, but with a substrate-
bound ACP intimately associated with the rest of the PKS. Swaps
which result in failure of TenC to reduce correctly are associated
with the C-MeT and JKR domains, although not with the KR,
suggesting that the trans-acting ER associates with C-MeT and
JKR.
Third, all active swaps still produce the native product 1,
either as the major product or as part of a mixture, again
indicating that there is no simple control of overall selectivity.
Finally, swaps within non-catalytic domains such as the JKR
(experiments 15–17) also lead to changes in methylation
pattern (e.g. compound 7), although not to changes in chain-
length.
All these factors suggest that extrinsic protein–protein
interactions between the catalytic domains can aﬀect the rates
at which they compete for ACP-bound intermediates. This is
supported by our previous results16 in which the cleanest
change in selectivity was observed when the complete C-MeT–
JKR–ER0–KR fragment was exchanged, consistent with the
limitation of introduction of deleterious extrinsic protein–
protein interactions.
The importance of extrinsic selectivity eﬀects is highlighted
by observation of the results from swaps of the fragments with
the lowest number of changes. For example, fragment 2B1 at the
C-terminus of C-MeT is 100% similar and 90% identical (e.g. 4
conservative changes in 40 AA) while fragment 4A is 92%
identical and 99% similar over 73 residues at the N-terminus of
the KR. Swap of fragment 4A (experiment 27) makes almost no
change to the programme; but swap of 2B1 (experiment 13)
produces tetraketides, compounds with changes to the meth-
ylation programme and unreduced shunts.
Close examination of the modelled structures of the TENS
b-processing domains shows that almost all mutations are
located at surface-exposed positions (Fig. 5A). Some of these
may account for the observed reduction in TenC ER activity by
impeding correct docking of this trans-acting component.
These variations may also contribute to altered domain–
domain interactions and hence changes in the relative rates
of C-MeT and KR domains. We also looked for the occurrence
of non-surface variations of residues away from the active
sites (Fig. 5B). Six residues fall into this class. Of these, two
pairs (V1433I, V1437M and I2223L, V2336I) appear to be in
contact in hydrophobic core regions of the C-MeT and KR
respectively, and two others do not seem to be located at
domain interfaces.Chem. Sci., 2019, 10, 8478–8489 | 8487
Fig. 7 Fungal polyketides produced by hybrid PKS-NRPS enzymes
with skipped methylation patterns.
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View Article OnlineConclusion
Our results support a programming mechanism for hr-PKS in
which individual catalytic domains such as the C-MeT and KR
clearly have a component of intrinsic selectivity for their
substrates. But, this selectivity is not the only feature deter-
mining overall programming when competition for diﬀerent
catalytic domains is possible. This is the case for the b-keto ACP
thiolester intermediates formed by the KS which can be
substrates for four diﬀerent catalytic domains (KR, C-MeT, C
and KS) in hybrid PKS-NRPS systems and it must be the ratios of
the intrinsic and extrinsic selectivities which determine the
nal outcome. Thus the overall programme appears to be based
on a complex balance of relative selectivities displayed by
several catalytic domains. These selectivities must change as the
chain grows and such eﬀects can clearly lead to complex
outcomes – for example the skipped methylation patterns
observed in prototenellin A 6, fusarin C 3747 and the ACE1 shunt
compound 3848 presumably means that for some intermediates
the C-MeT can again out-compete the KR (Fig. 7) in these
systems.
These conclusions also give hope that it may be possible to
predict the product of hr-PKS if the relative selectivities of
competing domains can be determined. Studies to determine
the selectivities of DH and ER domains are already underway in
our laboratories.25,26
Our results also suggest possible mechanisms by which
programming selectivity in fungal hr-PKS could evolve. For
example, fragment 2B1 of DMBS diﬀers from fragment 2B1 of
TENS by only 3 conservative changes (i.e. it is 100% similar and
92% identical). It contains 9 residues which likely make up the
substrate binding site, although none of these is mutated in the
DMBS sequence, but its exchange into TENS results in a signif-
icant erosion of delity such that ve diﬀerent compounds are
produced (exp. 13). Thus a small number of amino acid changes
in the synthase can lead to the production of several new
compounds. We have previously observed how other physical
changes such as the levels of gene expression and protein
production can similarly aﬀect product diversity in the tenellin
and related synthases.20,49
Similar observations of erosion of delity during biosyn-
thesis have been recently reported by Cane, Christianson and
coworkers in the arena of terpene cyclases.50 The creation of8488 | Chem. Sci., 2019, 10, 8478–8489a range of secondary metabolites of varied structure could give
an organism the possibility to rapidly respond to changing
environmental conditions. Production of a small library of
related products could more rapidly access compounds with
evolutionary utility than single step changes through a series of
compounds. Once a useful new compound is produced the
system could then more slowly optimise the library by restoring
delity to the newly selected secondary metabolite by mutations
of more distant residues. Our observations of this eﬀect in
iterative highly reducing fungal polyketide synthases suggests it
may be a phenomenon which occurs more generally.
Thus the results of this study strongly suggest that domain
swaps of individual domains, swaps of sub-domains, or even
possibly mutations of single amino acid residues, are unlikely
to lead to the predictable and clean production of desired
compounds without considering cognate mutations in
competing domains to alter their selectivities. In the short and
medium terms, and in the absence of high quality crystallo-
graphic data, it is likely to be more productive to exchange
multidomain fragments with the aim of preserving their deli-
cate balances of intrinsic and extrinsic selectivities, or make
precise and very limited changes to active sites with the hope of
changing substrate selectivity without inuencing protein–
protein interactions between domains. Such experiments, and
associated site-directed mutations are currently underway.Conﬂicts of interest
There are no conicts to declare.Acknowledgements
RJC, X-LY, KW and OP thank the University of Hannover for
funding. LCMS and NMR instrumentation were funded by the
University of Hannover and DFG (INST 187/621, INST 187/686-1,
CO 1328/3-1). SY thanks the Chinese Scholarship Council for
funding (CSC 2016 06210136). Dr Colin Lazarus, University of
Bristol, is thanked for the gi of C. militaris genomic DNA.Notes and references
1 (a) R. J. Cox, Org. Biomol. Chem., 2007, 5, 2010–2026; (b)
Y. H. Chooi and Y. Tang, J. Org. Chem., 2012, 77, 9933–9953.
2 Y. Ma, L. H. Smith, R. J. Cox, P. Beltran-Alvarez, C. J. Arthur
and T. J. Simpson, ChemBioChem, 2006, 7, 1951–1958.
3 D. A. Herbst, C. R. Huitt-Roehl, R. P. Jakob, J. M. Kravetz,
P. A. Storm, J. R. Alley, C. A. Townsend and T. Maier, Nat.
Chem. Biol., 2018, 14, 474–479.
4 (a) A. L. Vagstad, A. G. Newman, P. A. Storm, K. Belecki,
J. M. Crawford and C. A. Townsend, Angew. Chem., Int. Ed.,
2013, 52, 1718–1721; (b) J. M. Crawford, P. M. Thomas,
J. R. Scheerer, A. L. Vagstad, N. L. Kelleher and
C. A. Townsend, Science, 2008, 320, 243–246.
5 T. P. Nicholson, C. Wineld, J. Westcott, J. Crosby,
T. J. Simpson and R. J. Cox, Chem. Commun., 2003, 686–687.This journal is © The Royal Society of Chemistry 2019
Edge Article Chemical Science
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
0 
Ju
ly
 2
01
9.
 D
ow
nl
oa
de
d 
on
 1
1/
1/
20
19
 1
1:
13
:2
5 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online6 L. M. Halo, J. W. Marshall, A. A. Yakasai, Z. Song, C. P. Butts,
M. P. Crump, M. Heneghan, A. M. Bailey, T. J. Simpson,
C. M. Lazarus and R. J. Cox, ChemBioChem, 2008, 9, 585–594.
7 E. J. Skellam, Nat. Prod. Rep., 2017, 34, 1252–1263.
8 J. Kennedy, K. Auclair, S. G. Kendrew, C. Park, J. C. Vederas
and C. R. Hutchinson, Science, 1999, 284, 1368–1372.
9 R. J. Cox, F. Glod, D. Hurley, C. M. Lazarus, T. P. Nicholson,
B. A. M. Rudd, T. J. Simpson, B. Wilkinson and Y. Zhang,
Chem. Commun., 2004, 2260–2261.
10 K. E. Lebe and R. J. Cox, Chem. Sci., 2019, 10, 1227–1231.
11 R. Noani, K. de Mattos-Shipley, K. E. Lebe, L. C. Han,
Z. Iqbal, A. M. Bailey, C. L. Willis, T. J. Simpson and
R. J. Cox, Nat. Commun., 2018, 9, 3940.
12 L. Wang, M. Yuan and J. Zheng, Synth. Syst. Biotechnol., 2019,
4, 10–15.
13 B. D. Ames, C. Nguyen, J. Bruegger, P. Smith, W. Xu, S. Ma,
E. Wong, S. Wong, X. Xie, J. W.-H. Li, J. C. Vederas, Y. Tang
and S. C. Tsai, Proc. Natl. Acad. Sci. U. S. A., 2012, 109, 11144–
11149.
14 T. Maier, M. Leibundgut and N. Ban, Science, 2008, 321,
1315–1322.
15 D. A. Herbst, C. A. Townsend and T. Maier, Nat. Prod. Rep.,
2018, 35, 1046–1069.
16 K. M. Fisch, W. Bakeer, A. A. Yakasai, Z. Song, J. Pedrick,
Z. Wasil, A. M. Bailey, C. M. Lazarus, T. J. Simpson and
R. J. Cox, J. Am. Chem. Soc., 2011, 133, 16635–16641.
17 H. Jessen and K. Gademann, Nat. Prod. Rep., 2010, 27, 1168–
1185.
18 K. Schmidt, U. Riese, Z. Li and M. Hamburger, J. Nat. Prod.,
2003, 66, 378–383.
19 Y. Cheng, B. Schneider, U. Riese, B. Schubert, Z. Li and
M. Hamburger, J. Nat. Prod., 2004, 67, 1854–1858.
20 Z. Wasil, K. Pahirulzaman, C. P. Butts, T. J. Simpson,
C. M. Lazarus and R. J. Cox, Chem. Sci., 2013, 4, 3845–3856.
21 M. Heneghan, A. A. Yakasai, K. Williams, K. Kadir, Z. Wasil,
W. Bakeer, K. M. Fisch, A. M. Bailey, T. J. Simpson, R. J. Cox
and C. M. Lazarus, Chem. Sci., 2011, 2, 972–979.
22 S. M. Ma, J. W. H. Li, J. W. Choi, H. Zhou, M. K. K. Lee,
V. A. Moorthie, X. Xie, J. T. Kealey, N. A. Da Silva,
J. C. Vederas and Y. Tang, Science, 2009, 326, 589–592.
23 T. Kakule, Z. Lin and E. Schmidt, J. Am. Chem. Soc., 2014,
136, 17882–17890.
24 K. Pahirulzaman, K. Williams and C. M. Lazarus, Methods
Enzymol., 2012, 517, 241–260.
25 E. Liddle, A. Scott, L. C. Han, D. Ivison, T. J. Simpson,
C. L. Willis and R. J. Cox, Chem. Commun., 2017, 53, 1727–
1730.
26 D. M. Roberts, C. Bartel, A. Scott, D. Ivison, T. J. Simpson and
R. J. Cox, Chem. Sci., 2016, 8, 1116–1126.
27 J. Zheng, C. A. Taylor, S. K. Piasecki and A. T. Keatinge-Clay,
Structure, 2010, 18, 913–922.
28 A. Waterhouse, M. Bertoni, S. Bienert, G. Studer,
G. Tauriello, R. Gumienny, F. T. Heer, T. A. P. de Beer,
C. Rempfer, L. Bordoli, R. Lepore and T. Schwede, Nucleic
Acids Res., 2018, 46(W1), W296–W303.This journal is © The Royal Society of Chemistry 201929 S. Bienert, A. Waterhouse, T. A. P. de Beer, G. Tauriello,
G. Studer, L. Bordoli and T. Schwede, Nucleic Acids Res.,
2017, 45(D1), D313–D319.
30 N. Guex, M. C. Peitsch and T. Schwede, Electrophoresis, 2009,
30(Suppl 1), S162–S173.
31 P. Benkert, M. Biasini and T. Schwede, Bioinformatics, 2011,
27(3), 343.
32 M. Bertoni, F. Kiefer, M. Biasini, L. Bordoli and T. Schwede,
Sci. Rep., 2017, 7(1), 10480.
33 E. Krieger, K. Joo, J. Lee, J. Lee, S. Raman, J. Thompson,
M. Tyka, D. Baker and K. Karplus, Proteins: Struct., Funct.,
Bioinf., 2009, 77(Suppl 9), 114–122.
34 S. Forli, R. Huey, M. E. Pique, M. F. Sanner, D. S. Goodsell
and A. J. Olson, Nat. Protoc., 2016, 11(5), 905–919.
35 O. Trott and A. J. Olson, J. Comput. Chem., 2010, 31(2), 455–
461.
36 D. Seeliger and B. L. de Groot, J. Comput.-Aided Mol. Des.,
2010, 24(5), 417–422.
37 W. D. Fiers, G. J. Dodge, D. H. Sherman, J. L. Smith and
C. C. Aldrich, J. Am. Chem. Soc., 2016, 138, 16024–16036.
38 M. A. Skiba, A. P. Sikkema, W. D. Fiers, W. H. Gerwick,
D. H. Sherman, C. C. Aldrich and J. L. Smith, ACS Chem.
Biol., 2016, 11, 3319–3327.
39 D. L. Akey, J. R. Razelun, J. Tehranisa, D. H. Sherman,
W. H. Gerwick and J. L. Smith, Structure, 2010, 18, 94–105.
40 A. E.-L. Busche, D. Gottstein, C. Hein, N. Ripin, I. Pader,
P. Tufar, E. B. Eisman, L. Gu, C. T. Walsh, D. H. Sherman,
F. Lo¨hr, P. Gu¨ntert and V. Do¨tsch, ACS Chem. Biol., 2012,
7, 378–386.
41 H. Shafran, I. Miyara, R. Eshed, D. Prusky and A. Sherman,
Fungal Genet. Biol., 2008, 45, 1147–1154.
42 M. D. Koziol, Ph.D. thesis, Investigating Programming and
Production of Fungal Polyketide Synthases, University of
Bristol, 2014.
43 R. A. Cacho, J. Thuss, W. Xu, R. Sanichar, Z. Gao, A. Nguyen,
J. C. Vederas and Y. Tang, J. Am. Chem. Soc., 2015, 137,
15688–15691.
44 P. A. Storm, P. Pal, C. R. Huitt-Roehl and C. A. Townsend,
ACS Chem. Biol., 2018, 13, 3043–3048.
45 Y. Seshime, P. R. Juvvadi, M. Tokuoka, Y. Koyama,
K. Kitamoto, Y. Ebizuka and I. Fujii, Bioorg. Med. Chem.
Lett., 2009, 19, 3288–3292.
46 P. Beltran-Alvarez, R. J. Cox, J. Crosby and T. J. Simpson,
Biochemistry, 2007, 46, 14672–14681.
47 Z. Song, R. J. Cox, C. M. Lazarus and T. J. Simpson,
ChemBioChem, 2004, 5, 1196–1203.
48 Z. Song, W. Bakeer, J. W. Marshall, A. A. Yakasai,
R. M. Khalid, J. Collemare, E. J. Skellam, D. Tharreau,
M. H. Lebrun, C. M. Lazarus, A. M. Bailey, T. J. Simpson
and R. J. Cox, Chem. Sci., 2015, 6, 4837–4845.
49 A. A. Yakasai, J. Davison, Z. Wasil, L. M. Halo, C. P. Butts,
C. M. Lazarus, A. M. Bailey, T. J. Simpson and R. J. Cox, J.
Am. Chem. Soc., 2011, 133, 10990–10998.
50 (a) M. J. Rynkiewicz, D. E. Cane and D. W. Christianson,
Biochemistry, 2002, 41, 1732–1741; (b) R. Li, W. Chou,
J. Himmelberger, K. Litwin, G. Harris, D. E. Cane and
D. W. Christianson, Biochemistry, 2014, 53, 1155–1168.Chem. Sci., 2019, 10, 8478–8489 | 8489
